By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Conatus Pharmaceuticals Inc. 

4365 Executive Drive
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-457-7221 Fax: 858-558-8920



Start Up

Company News
Conatus Pharma Announces Effectiveness Of Exclusive License For Global Development And Commercialization Of Emricasan With Receipt Of $7 Million Payment 7/7/2017 10:36:58 AM
FDA Grants Conatus Pharma Orphan Drug Designation For IDN-7314 For The Treatment Of PSC 6/26/2017 12:18:49 PM
Conatus Pharma Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/17/2017 11:18:08 AM
Conatus Pharma Announces Proposed Public Offering Of Common Stock 5/11/2017 12:58:22 PM
Conatus Pharma Announces Pricing Of Public Offering Of Common Stock 5/11/2017 8:45:57 AM
Novartis AG (NVS) Dives Deeper Into NASH With Exclusive Deal With Conatus Pharma 5/4/2017 6:41:25 AM
Conatus Pharma To Report First Quarter 2017 Financial Results 4/28/2017 10:46:03 AM
Conatus Pharma Posters At EASL Meeting Address MELD Score Dynamics And Outcomes In Decompensated Liver Cirrhosis Patients, Including NASH Patients, Awaiting Liver Transplantation 4/21/2017 8:25:43 AM
SoCal Biotech Conatus Pharma to Receive $50 Million in Liver Drug Deal with Pharm Giant Novartis AG (NVS) 12/20/2016 6:40:59 AM
Conatus Pharma Reports Third Quarter 2016 Financial Results And Program Updates 11/9/2016 8:32:26 AM